Fluorometholone ophthalmic suspension is a corticosteroid indicated for treating steroid-responsive inflammatory conditions of the eye's anterior segment. "Our team has worked tirelessly to bring this ...
The Company received 180-day competitive generic therapy exclusivity from the FDA. The first generic version of FML suspension (fluorometholone ophthalmic suspension) has been made available by Amneal ...
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Applications (NDAs) ...
The MarketWatch News Department was not involved in the creation of this content. MIRAMAR, Fla., Feb. 12, 2026 /PRNewswire/ -- DifGen Pharmaceuticals, a leading US based generic pharmaceutical company ...
John Kempen, MD, MPH, PhD, MHS, Director of Epidemiology for Ophthalmology at Mass Eye and Ear and Harvard Medical School, is the lead author of a paper published in The Lancet Global Health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results